肝癌骨转移:分子机制和治疗见解
Jing Sun1, Lei Liu2, Hanqing Zhang1
1Department of Spine Surgery, The Ninth Medical Center of Chinese PLA General Hospital, Beijing, 100101, China.
Current topics in medicinal chemistry
|November 5, 2025
概括
肝癌的骨转移包括表皮细胞-介质细胞过渡 (EMT),循环瘤细胞 (CTC) 和肝癌干细胞 (LCSC). 了解这些机制及其相互作用是开发新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移研究 癌症转移研究
背景情况:
- 肝癌是侵略性的,骨转移显著恶化预后.
- 肝癌骨转移的分子驱动因素尚未完全理解.
研究的目的:
- 审查了解肝癌骨转移的近期进展.
- 专注于表皮细胞-介质细胞过渡 (EMT),循环瘤细胞 (CTC) 和肝癌干细胞 (LCSC).
主要方法:
- 对最近的进展进行文献综述.
- 专注于表面标记物,骨髓利基相互作用和信号通路.
- 在肝癌骨转移中检查EMT,CTC和LCSC.
主要成果:
- 肝癌骨转移是由EMT,CTC和LCSC殖民驱动的.
- 特定的表面标记物 (例如CD133,CD44) 影响瘤异质性和治疗耐药性.
- 关键过程涉及骨质细胞-骨质细胞-癌症干细胞 (OB-OC-CSC) 轴和CXCL12-CXCR4信号传递.
结论:
- 对EMT,LCSC和OB-OC-CSC交叉通话的洞察力提供了潜在的治疗目标.
- 需要进一步的研究来验证标记物,了解休眠状态,并探索免疫调节策略.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K


